The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
With the current crisis related to the emergence of carbapenem-resistant Gram-negative bacteria (CR-GNB), classical treatment approaches with so-called “old-fashion antibiotics” are generally unsatisfactory. Newly approved β-lactam/β-lactamase inhibitors (BLBLIs) should be considered as the first-line treatment options for carbapenem-resistant Ente...
Alternative Titles
Full title
The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_77d8d7a55e6640a4845d04f3a9c80148
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_77d8d7a55e6640a4845d04f3a9c80148
Other Identifiers
ISSN
2079-6382
E-ISSN
2079-6382
DOI
10.3390/antibiotics11020277
